A Klatskin Tumor is a type of cancer in the bile ducts, near where the right and left ducts join. It's a specific kind of cholangiocarcinoma.
Every report comes from a Lived member, sent anonymously.
Have you tried Gemcitabine for Klatskin Tumor?
A Klatskin tumor is a cancer of the bile ducts that starts at the point where the right and left bile ducts leave the liver and join into one duct. Doctors also call it perihilar or hilar cholangiocarcinoma, because that junction is known as the hilum of the liver. It is the most common location for bile duct cancer, accounting for roughly half of cases, although bile duct cancer as a whole is rare. Bile is a digestive fluid made by the liver, and these ducts carry it toward the intestine. A tumor at the hilum can narrow or block that flow even when it is still small, so the first signs are usually signs of bile backing up: yellowing of the skin and eyes (jaundice), itching, dark urine, pale or greasy stools, loss of appetite and weight loss. Belly pain is less common early on. These symptoms have many more common causes, such as gallstones or hepatitis, but together they always deserve a prompt medical assessment.
Most Klatskin tumors develop without a clear cause, and many people who get one have no known risk factor. What the recognized risk factors share is long-term irritation or inflammation of the bile ducts. The best known is primary sclerosing cholangitis (PSC), a disease in which the bile ducts become inflamed and scarred over years; it often occurs alongside ulcerative colitis, which also raises risk. Cysts in the bile ducts that a person is born with, stones inside the ducts, cirrhosis, and hepatitis B or C are also linked to bile duct cancer. In parts of Southeast Asia and China, infection with liver flukes (small parasitic worms caught from raw or undercooked freshwater fish) is a major cause. Risk also rises with age, and most people are diagnosed in their 60s or 70s. Obesity, diabetes and smoking have been associated with higher risk, but these links are weaker and do not mean any one factor caused a particular person's cancer.
Diagnosis usually begins when jaundice or abnormal blood tests prompt a search for a blockage. Liver blood tests often show raised bilirubin, the yellow pigment that causes jaundice, and alkaline phosphatase, an enzyme that rises when bile cannot drain. Tumor markers called CA 19-9 and CEA may be elevated, but they can also rise with a simple blockage or infection, and some bile duct cancers do not raise them at all, so they support the picture rather than settle it. Imaging is central. CT scans and MRI show the tumor and its relation to nearby blood vessels, and a special MRI of the bile ducts (MRCP) maps exactly where the ducts narrow. Because the tumor sits where the main ducts and the liver's blood supply meet, this detail is what decides whether surgery is possible. Endoscopic procedures such as ERCP, in which a flexible scope is passed through the mouth to the bile duct opening, can collect brushings or tissue and relieve the blockage at the same time. A biopsy is not always done first. If imaging clearly shows a tumor that can be removed, the surgical team may proceed and treat it as bile duct cancer, with the removed tissue confirming the diagnosis. When treatment with medicines is planned, the tumor tissue may also be tested for gene changes that open up targeted drug options.
Surgery to remove the tumor completely is the main route to a possible cure. For a Klatskin tumor this usually means removing the affected bile ducts together with part of the liver and nearby lymph nodes, then reconnecting the remaining ducts to the intestine. It is a major operation with a real risk of serious complications, including bile leaks, infection and liver failure, so it is best planned and performed at a center with a specialized liver and bile duct team. Only a minority of people are candidates when first diagnosed, and a second opinion from such a center is reasonable before concluding that surgery is not possible. After surgery, about six months of capecitabine (Xeloda), a chemotherapy pill, is usually offered to lower the chance of the cancer returning. For some people whose tumor cannot be removed but has not spread, a few transplant centers offer chemotherapy and radiation followed by a liver transplant. Selection is strict, and some people who start the program do not reach transplant because the cancer grows while they wait or the pretreatment is too hard to tolerate, but for those who complete it, long-term survival has been considerably better than for unresectable disease treated without surgery. When the cancer cannot be removed or has spread, the standard first treatment combines the chemotherapy drugs gemcitabine and cisplatin with an immunotherapy drug, durvalumab (Imfinzi) or pembrolizumab (Keytruda), which helps the immune system attack the cancer. This does not cure the cancer, but it can slow it and help people live longer. Testing the tumor for specific gene changes can point to targeted drugs as later options for a minority of people. Radiation can be used to control the tumor or relieve symptoms, and clinical trials are often worth asking about. Relieving the blockage is part of almost every treatment plan. A stent (a small plastic or metal tube placed inside the duct, usually during ERCP) or a drainage tube placed through the skin into the liver lets bile flow again, which eases jaundice and itching and can make surgery or chemotherapy safer. Stents and drains can clog or become infected and often need to be replaced every few months.
The outlook depends mostly on whether the tumor can be removed. Most Klatskin tumors are found after they have grown into nearby structures, which is why many people are treated to control the cancer rather than cure it. When complete surgery is possible, some people remain free of cancer long term, although recurrence is common. For advanced disease, treatment aims to extend life and keep symptoms manageable, and individual courses vary widely, from months to several years. Daily life is often shaped by bile drainage as much as by the cancer itself. People may live with a stent or an external drain and bag, learn how to care for it, and return for procedures to replace or clear it. Recovery from liver surgery takes weeks to months, and appetite, digestion and energy can take time to return. Chemotherapy is usually given in cycles of a few weeks with regular blood tests. After treatment, follow-up visits with scans and blood tests are typically every few months at first. Palliative care, a specialty focused on symptoms such as itching, pain, poor appetite and fatigue, can be involved from diagnosis alongside cancer treatment. Because the outlook can change quickly, many people find it helpful to discuss their goals and plans for future care early, while they can take a full part in decisions.
See a doctor promptly, ideally the same day, for new yellowing of the skin or eyes, especially with itching, dark urine or pale stools. For anyone with a Klatskin tumor, and particularly with a stent or drain, call the care team right away for fever, chills, returning or worsening jaundice, or new pain in the upper right belly. These can signal a blocked stent or a bile duct infection (cholangitis), which needs quick treatment with antibiotics and drainage. Fever with confusion, fainting or rapidly worsening illness can mean the infection has spread to the blood and needs emergency care. Also contact the team if a drain leaks, falls out or stops draining, or if weight loss, poor appetite or side effects of treatment are making it hard to keep going.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Klatskin Tumor is like, what's helped you, or ask the community a question.